当前位置:首页 - 行情中心 - 三星医疗(601567) - 财务分析

三星医疗

(601567)

  

流通市值:319.54亿  总市值:319.54亿
流通股本:14.05亿   总股本:14.05亿

三星医疗(601567)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润15.07亿元,每股收益1.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1266650.57万元,未分配利润715642.92万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2415689.43万元,负债1149038.86万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入11,079,882,3577,972,213,807.133,630,793,866.3114,600,478,206.12
营业总成本9,754,661,366.816,798,039,087.953,129,719,427.7312,231,892,536.68
其他经营收益
营业利润1,770,190,564.161,381,832,722.13567,140,535.342,585,133,167.2
利润总额1,780,027,309.51,401,225,534.45568,591,856.182,672,556,622.6
净利润1,506,796,242.671,214,913,297.1480,485,140.962,273,237,462.35
每股收益
其他综合收益520,929.5444,675,974.2714,203,090.27-3,372,669.3
综合收益总额1,507,317,172.211,259,589,271.37494,688,231.232,269,864,793.05
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计12,810,166,281.8312,113,369,983.5213,652,778,344.6113,799,708,831.46
非流动资产:
非流动资产合计11,346,728,040.211,133,197,466.8310,877,442,319.2410,676,777,755.47
资产总计24,156,894,322.0423,246,567,450.3524,530,220,663.8524,476,486,586.93
流动负债:
流动负债合计9,818,854,237.369,099,227,634.337,568,086,008.097,810,359,014.98
非流动负债:
非流动负债合计1,671,534,374.961,737,271,970.784,153,885,006.624,392,189,417.12
负债合计11,490,388,612.3210,836,499,605.1111,721,971,014.7112,202,548,432.1
所有者权益(或股东权益):
归属于母公司股东权益合计12,419,748,917.3512,163,751,451.3512,590,896,965.1312,081,698,336.27
股东权益合计12,666,505,709.7112,410,067,845.2412,808,249,649.1412,273,938,154.83
负债和股东权益合计24,156,894,322.0423,246,567,450.3524,530,220,663.8524,476,486,586.93
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计10,404,489,143.436,382,448,016.253,034,317,675.116,356,780,728.03
经营活动现金流出小计9,946,477,855.676,441,704,293.193,182,751,953.5814,520,596,284.37
经营活动产生的现金流量净额458,011,287.76-59,256,276.94-148,434,278.481,836,184,443.66
投资活动产生的现金流量:
投资活动现金流入小计5,316,004,728.85,294,866,108.53,598,842,167.41,649,942,466.89
投资活动现金流出小计5,198,399,076.785,060,947,294.394,138,136,988.873,676,681,277.73
投资活动产生的现金流量净额117,605,652.02233,918,814.11-539,294,821.47-2,026,738,810.84
筹资活动产生的现金流量:
筹资活动现金流入小计1,864,946,678.011,466,320,508.08186,824,435.724,168,259,423.7
筹资活动现金流出小计4,128,771,066.063,322,976,017.7690,919,418.464,797,473,280.77
筹资活动产生的现金流量净额-2,263,824,388.05-1,856,655,509.6895,905,017.26-629,213,857.07
汇率变动对现金及现金等价物的影响-38,387,149.15-19,449,773.8948,560,723.57-82,220,480.64
现金及现金等价物净增加额-1,726,594,597.42-1,701,442,746.4-543,263,359.12-901,988,704.89
期末现金及现金等价物余额2,414,102,576.012,439,254,427.033,597,433,814.314,140,697,173.43
补充资料:
现金及现金等价物的净增加额--1,701,442,746.4--901,988,704.89
最新报告期:2025-10-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华鑫证券张涵1.762.142.622025-10-19
中信建投朱玥,王在存,贺菊颖,郑博元1.832.19--2025-09-13
中信证券华夏,陈竹,华鹏伟,沈睦钧1.842.212.642025-08-26
国信证券王晓声,王蔚祺1.802.262.852025-08-25
野村东方国际证券李沛雨,马晓明1.822.242.682025-08-22
TOP↑